Gumbo, T., & Alffenaar, J. C. (2018). Pharmacokinetic/Pharmacodynamic Background and Methods and Scientific Evidence Base for Dosing of Second-line Tuberculosis Drugs. Clinical infectious diseases, 67(suppl_3), S267. https://doi.org/10.1093/cid/ciy608
Chicago-Zitierstil (17. Ausg.)Gumbo, Tawanda, und Jan-Willem C. Alffenaar. "Pharmacokinetic/Pharmacodynamic Background and Methods and Scientific Evidence Base for Dosing of Second-line Tuberculosis Drugs." Clinical Infectious Diseases 67, no. suppl_3 (2018): S267. https://doi.org/10.1093/cid/ciy608.
MLA-Zitierstil (9. Ausg.)Gumbo, Tawanda, und Jan-Willem C. Alffenaar. "Pharmacokinetic/Pharmacodynamic Background and Methods and Scientific Evidence Base for Dosing of Second-line Tuberculosis Drugs." Clinical Infectious Diseases, vol. 67, no. suppl_3, 2018, p. S267, https://doi.org/10.1093/cid/ciy608.